EUVIMEDEUVIMED entdecken
Open Access

Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD

Fahim Ebrahimi, Jialu Yao, Hannes Hagström, Olof Stephansson, Jiangwei Sun, David Bergman, Jonas Söderling, Jonas F Ludvigsson

JAMA Network Open · 10.09.2024 · 7 (9) · e2432420

DOI: 10.1001/jamanetworkopen.2024.32420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 10.09.2024. Verfasst von Fahim Ebrahimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Birth Weight, Gestational Age. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Metabolic dysfunction–associated steatotic liver disease (MASLD) has become the most common chronic liver disease worldwide and is increasingly being diagnosed at younger ages, affecting more than one-third of young people with obesity.

Objective

To evaluate associations between perinatal conditions and risk of MASLD and associated progressive liver disease. Design, Setting, and Participants This nationwide, population-based case-control study included all biopsy-confirmed cases of MASLD in Sweden. Individuals aged 25 years or younger (hereafter, young individuals) with biopsy-proven MASLD between January 1, 1992, and December 31, 2016, were matched to up to 5 general population control individuals. Granular data on maternal and perinatal characteristics were retrieved from the Swedish Medical Birth Register. Data were analyzed from June 2023 to June 2024. Exposures Birth weight (low [<2500 g], reference [2500 to <4000 g], or high [≥4000 g]), gestational age (GA), and birth weight for GA (small for GA [SGA; <10th percentile], appropriate for GA [10th-90th percentile], or large for GA [LGA; >90th percentile]), compared between patients and matched controls. Main Outcomes and Measures The main outcome was odds of biopsy-proven MASLD and MASLD-associated progressive liver disease (ie, liver fibrosis or cirrhosis) according to birth weight, GA, and birth weight for GA, adjusted for matching factors.

Results

In total, 165 young individuals with biopsy-proven MASLD (median age at diagnosis: 12.0 years [IQR, 4.4-16.9 years]; 100 [60.6%] male) were matched with 717 controls. There was an association between low birth weight and future development of MASLD (adjusted odds ratio [AOR], 4.05; 95% CI, 1.85-8.88) but no association between high birth weight and odds of MASLD (AOR, 0.64; 95% CI, 0.38-1.08) compared with the reference birth weight. An association was seen for SGA (AOR, 3.36; 95% CI, 2.00-5.64) compared with appropriate size for GA (reference category) but not for LGA (AOR, 0.57; 95% CI, 0.27-1.20). Progressive liver disease was more common in individuals born with low birth weight (AOR, 6.03; 95% CI, 1.66-21.87) or SGA (AOR, 4.90; 95% CI, 2.15-11.14). Conclusions and Relevance In this nationwide study of young individuals with biopsy-proven MASLD, low birth weight and SGA were associated with development of MASLD and progressive liver disease, suggesting a need for structured screening measures to diagnose these conditions early in high-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Birth WeightGestational AgeHumansFemaleCase-Control StudiesMaleSwedenAdolescentChildRisk FactorsInfant, NewbornFatty LiverChild, PreschoolAdultYoung Adult

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Gastroenterology and Hepatology, Clarunis University Center for Gastrointestinal and Liver Diseases, Basel, Switzerland.
  • Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.
  • Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

Zitieren

APA

Ebrahimi, F., Yao, J., Hagström, H., Stephansson, O., Sun, J., Bergman, D., Söderling, J., & Ludvigsson, J. F. (2024). Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD. JAMA Network Open, 7(9), e2432420. https://doi.org/10.1001/jamanetworkopen.2024.32420

Vancouver

Ebrahimi F, Yao J, Hagström H, Stephansson O, Sun J, Bergman D, et al. Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD. JAMA Network Open. 2024;7(9):e2432420. doi:10.1001/jamanetworkopen.2024.32420

BibTeX
@article{Ebrahimi2024,
  author = {Ebrahimi, Fahim and Yao, Jialu and Hagström, Hannes and Stephansson, Olof and Sun, Jiangwei and Bergman, David and Söderling, Jonas and Ludvigsson, Jonas F},
  title = {Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {9},
  pages = {e2432420},
  doi = {10.1001/jamanetworkopen.2024.32420}
}
Kostenlos starten →